Instrument Inactif

Communiqués Furiex Pharmaceuticals Inc

Actions

US36106P1012

Recherche biotechnologique et médicale

Cours en clôture Nasdaq
- ^USD	-

28/04/14	Bank of America : Wall Street ouvre en hausse, les pharmaceutiques en vue	RE
28/04/14	Wall Street ouvre en hausse, les pharmaceutiques en vue	RE

Communiqués

02/07/14	Furiex Pharmaceuticals : Actavis Completes Acquisition of Furiex Pharmaceuticals	PR
01/07/14	Furiex Pharmaceuticals : Stockholders Approve Acquisition by Actavis; Ukrainian Antimonopoly Committee Clears Proposed Merger	BU
13/05/14	Furiex Pharmaceuticals : INVESTOR ALERT: Levi & Korsinsky, LLP Notifies Investors of Furiex Pharmaceuticals, Inc. of Claims Against Board of Directors of Company In Connection With the Sale of the Company to Forest Laboratories, Inc. -- FURX	BU
07/05/14	Furiex Pharmaceuticals : Reports First Quarter 2014 Financial Results	BU
02/05/14	Furiex Pharmaceuticals : INVESTOR ALERT – FURIEX PHARMACEUTICALS, INC.: The Law Offices of Vincent Wong Investigates the Sale of Furiex Pharmaceuticals, Inc.	BU
30/04/14	Furiex Pharmaceuticals : INVESTOR ALERT - FURIEX PHARMACEUTICALS, INC.: The Law Offices of Vincent Wong Investigates the Sale of Furiex Pharmaceuticals, Inc. -- FURX	PR
29/04/14	Furiex Pharmaceuticals : Ryan & Maniskas, LLP : Announces Investigation of Furiex Pharmaceuticals, Inc.	PR
29/04/14	Furiex Pharmaceuticals : INVESTOR ALERT Levi & Korsinsky, LLP Announces Investigation of Furiex Pharmaceuticals, Inc. and Its Board of Directors In Connection With the Sale of the Company to Forest Laboratories, Inc. -- FURX	PR
29/04/14	Furiex Pharmaceuticals : Law Firm Kirby McInerney LLP Investigating Potential Claims on Behalf of Furiex Pharmaceuticals, Inc. Stockholders	BU
28/04/14	Furiex Pharmaceuticals : Morgan & Morgan : Announces the Investigation of Furiex Pharmaceuticals, Inc. FURX	PR
28/04/14	Furiex Pharmaceuticals : Stockholders Encouraged to Contact Securities Law Firm about Takeover	PR
28/04/14	Furiex Pharmaceuticals : INVESTOR ALERT Levi & Korsinsky, LLP Announces Investigation of Furiex Pharmaceuticals, Inc. and Its Board of Directors In Connection With the Sale of the Company to Forest Laboratories, Inc.	BU
28/04/14	Furiex Pharmaceuticals : INVESTOR ALERT Levi & Korsinsky, LLP Announces Investigation of Furiex Pharmaceuticals, Inc. and Its Board of Directors In Connection With the Sale of the Company to Forest Laboratories, Inc.	BU
28/04/14	Furiex Pharmaceuticals : Newman Ferrara LLP : Announces Investigation of Furiex Pharmaceuticals, Inc.	BU
28/04/14	Furiex Pharmaceuticals : ALERT: Proposed Buyout of Pharmaceuticals under Investigation by Johnson & Weaver, LLP	BU
07/04/14	Furiex Pharmaceuticals : Announces First Quarter 2014 Earnings Release and Conference Call	BU
03/04/14	Furiex Pharmaceuticals : Announces Acceptance to Late-Breaking Abstract Session at Digestive Disease Week 2014	BU
27/03/14	Furiex Pharmaceuticals : Confirms Takeda Will Present Additional Data from the EXAMINE Trial at the American College of Cardiology's 63rd Annual Scientific Session	PU
27/03/14	Furiex Pharmaceuticals : Confirms Takeda Will Present Additional Data from the EXAMINE Trial at the American College of Cardiology’s 63rd Annual Scientific Session	BU
11/03/14	Furiex Pharmaceuticals Inc : Furiex Pharmaceuticals Reports Fourth Quarter and Full-Year 2013 Financial Results	BU
07/03/14	Furiex Pharmaceuticals Inc : Furiex Pharmaceuticals Confirms Takeda's Submission of a New Drug Application for Trelagliptin Succinate (SYR-472) in Japan for the Treatment of Type 2 Diabetes	BU
10/02/14	Furiex Pharmaceuticals Inc : Furiex Pharmaceuticals Announces Fourth Quarter 2013 Earnings Release and Conference Call	BU
04/02/14	Furiex Pharmaceuticals Inc : Furiex Pharmaceuticals Announces Positive Top-Line Results of Two Pivotal Phase III Clinical Trials of Eluxadoline in Patients with IBS-d	BU
05/11/13	Furiex Pharmaceuticals Inc : Furiex Reports Third Quarter 2013 Financial Results	BU
31/10/13	Furiex Pharmaceuticals Inc : Furiex Pharmaceuticals Announces Priligy® Launch in the United Kingdom by Menarini	BU